AGING BRAIN AND DOPAMINE-RECEPTORS - ABNORMAL REGULATION BY CCK-8 OF H-3-SPIPERONE LABELED DOPAMINE-RECEPTORS IN STRIATAL MEMBRANES

被引:5
作者
AGNATI, LF
FUXE, K
BATTISTINI, N
BENFENATI, F
机构
[1] UNIV MODENA,DEPT ENDOCRINOL,I-41100 MODENA,ITALY
[2] KAROLINSKA INST,DEPT HISTOL,S-10401 STOCKHOLM 60,SWEDEN
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1984年 / 120卷 / 03期
关键词
D O I
10.1111/j.1748-1716.1984.tb07407.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:465 / 467
页数:3
相关论文
共 10 条
[1]   DIFFERENTIAL MODULATION BY CCK-8 AND CCK-4 OF [H-3]SPIPERONE BINDING-SITES LINKED TO DOPAMINE AND 5-HYDROXYTRYPTAMINE RECEPTORS IN THE BRAIN OF THE RAT [J].
AGNATI, LF ;
FUXE, K ;
BENFENATI, F ;
CELANI, MF ;
BATTISTINI, N ;
MUTT, V ;
CAVICCHIOLI, L ;
GALLI, G ;
HOKFELT, T .
NEUROSCIENCE LETTERS, 1983, 35 (02) :179-183
[2]   NEUROPEPTIDE-Y INVITRO SELECTIVELY INCREASES THE NUMBER OF ALPHA-2-ADRENERGIC BINDING-SITES IN MEMBRANES OF THE MEDULLA-OBLONGATA OF THE RAT [J].
AGNATI, LF ;
FUXE, K ;
BENFENATI, F ;
BATTISTINI, N ;
HARFSTRAND, A ;
TATEMOTO, K ;
HOKFELT, T ;
MUTT, V .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 118 (03) :293-295
[3]  
AGNATI LF, 1982, MED BIOL, V60, P183
[4]   ON THE FUNCTIONAL-ROLE OF COEXISTENCE OF 5-HT AND SUBSTANCE-P IN BULBOSPINAL 5-HT NEURONS - SUBSTANCE-P REDUCES AFFINITY AND INCREASES DENSITY OF H-3-5-HT BINDING-SITES [J].
AGNATI, LF ;
FUXE, K ;
BENFENATI, F ;
ZINI, I ;
HOKFELT, T .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 117 (02) :299-301
[5]  
Cochran W.G, 1957, STAT METHODS, V6th ed
[6]   H-3-SPIROPERIDOL LABELS DOPAMINE RECEPTORS IN PITUITARY AND BRAIN [J].
CREESE, I ;
SCHNEIDER, R ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (04) :377-381
[7]   MODULATION BY CHOLECYSTOKININS OF H-3-SPIROPERIDOL BINDING IN RAT STRIATUM - EVIDENCE FOR INCREASED AFFINITY AND REDUCTION IN THE NUMBER OF BINDING-SITES [J].
FUXE, K ;
AGNATI, LF ;
BENFENATI, F ;
CIMMINO, M ;
ALGERI, S ;
HOKFELT, T ;
MUTT, V .
ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 113 (04) :567-569
[8]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[9]  
REISINE TD, 1980, AGING-US, V13, P147
[10]  
SEEMAN P, 1980, PHARMACOL REV, V32, P229